Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopaminergic Neuromodulation of Decision Making
NCT03512171Phase 1Completed
- Sponsor
- Vanderbilt University
- Start
- Mar 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dextroamphetamine, sponsored by Vanderbilt University. Primary endpoint: Dopamine D2 receptor availability (binding potential). Started Mar 2016; status: completed.
02
Drugs
dextroamphetamine
Beyond the preview
Go deeper on NCT03512171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03512171.